, we learned that all patients with CLTI should
receive best medical therapy, including antithrombotic,
lipid-lowering, antihypertensive and glycemic control
medications, preventive foot care and counseling on
smoking cessation, a low-fat and low-sodium diet, and
appropriate exercise.
Third, we learned that Evidence-Based Revascularization (EBR) depends on Patient risk, Limb severity, and
ANatomic complexity (PLAN). The proposed